BBP
ADMA icon

Banco BTG Pactual’s ADMA Biologics ADMA Stock Holding History

Banco BTG Pactual’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-92,500
Closed -$105K – 51
2021
Q3 		$105K Hold
92,500
– – 0.04% 99
2021
Q2 		$148K Hold
92,500
– – 0.1% 88
2021
Q1 		$163K Buy
+92,500
New +$212K 0.06% 100

Other funds holding ADMA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Banco BTG Pactual's ADMA Position: Q4 2021 in Review

Banco BTG Pactual sold out of ADMA Biologics (ADMA) in Q4 2021, closing a stake of 92,500 shares — an estimated $105K sold.

Banco BTG Pactual first reported a position in ADMA in Q1 2021 and held it in 3 quarters. The position peaked at $163K in Q1 2021. 88 funds tracked by Wall St. Rank hold ADMA as of Q4 2021.

  • Banco BTG Pactual reported no remaining ADMA Biologics position as of Q4 2021 after selling out during the quarter.
  • Banco BTG Pactual sold 92,500 ADMA Biologics shares in Q4 2021, an estimated $105K.
  • Banco BTG Pactual first reported a position in ADMA Biologics in Q1 2021 and held it in 3 quarters.
  • Banco BTG Pactual's ADMA Biologics position peaked at $163K in Q1 2021.
  • 88 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2021.

Based on Banco BTG Pactual's 13F filing for Q4 2021, filed 12 May 2022.